Streptococcus Flashcards

1
Q

Characteristics of Streptococci

A

Gram-positive cocci arranged in pairs or chains
Most species are facultatively anaerobic
Ferment carbohydrates resulting in lactic acid production
Catalase negative (as opposed to staphylococci)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of Streptococci

A

1) Cell wall carbohydrate antigens recognized by specific antibodies
2) Hemolytic pattern on agar containing blood cells
3) Biochemical properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Hemolytic Pattern on agar containing blood cells

A

Alpha - partial hemolysis or “greening”
Beta - Complete clearing
Gamma - no change in red blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Lancefield typing can recognize…

A

Group A Streptococci = S. pyogenes
Group B Streptococci = S. agalactiae
Group C = S. Dysgalactiae
Group F = S. Anginosus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

S. Pyogenes pathology

A

Pharyngitis
Skin and soft tissue infections
Rheumatic fever
Glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

S. Agalactiae pathology

A

Neonatal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

S. Dysgalactiae pathology

A

Pharyngitis

Acute glomerulonephritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

S. Pneumoniae pathology

A

Otitis media
Pneumonia
Sepsis, meningitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Surface Proteins for S. pyogenes
Group specific:
Type specific:
Others:

A

Group specific: Lancefield Group A carbohydrate
Type specific: M proteins encoded by emm genes - epidemiologic markers
Others:
- M-like proteins
- hyaluronic acid capsule
- C5a peptidase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Proteins that mediate adherence to fibronectin

A

Lipoteichoic acid

F Protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Avoidance of opsonization and phagocytosis

A
  • Hyaluronic acid capsule
  • M proteins block C3b binding
  • M like proteins bind the Fc fragment of antibodies which reduces bound C3b
  • C5a peptidase degrades C5a
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Invasion of host cells

A

M protein and F protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Toxins and Enzymes

A
Streptococcal pyogenic exotoxins SpeA, B, C and F - phage encoded, act as superantigens
- Mediate cytokine storm
Streptolysin S
Streptolysin O
Streptokinase
Dnases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Spe toxins mediate what manifestations of S. pyogenes infections?

A
  1. Cytokine release may be key to the severity of necrotizing fascitis and toxic shock syndrome
  2. Responsible for rash in patients with scarlet fever
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Streptolysin S

A

Oxygen and serum stable cell-bound hemolysin, responsible for complete lysis of red blood cells - kills macrophages and neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Sterptolysin O

A

Oxygen labile hemolysin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Streptokinase

A

Mediates cleavage of plasminogen, the release of plasmin and subsequent cleavage of fibrin and fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Dnases

A

Depolymerize released DNA from lysed cells aiding spread of streptococci through infected tissues

19
Q

Streptococcus Pyogenes: Patients with antibodies to ___ _______ are protected

A

M proteins

20
Q

Streptococcus Epidemiology

A
  • Transient colonizer of the oropharynx of healthy children and adults
  • Spread by droplet transmission
  • Pharyngitis affects children between 5 and 15 y
  • Soft tissue infections by organisms introduced into superficial or deep tissues through a wound
21
Q

Streptococcal pharyngitis

A

redness and edema of the mucous membranes, fever, pus, tonsilitis

22
Q

Scarlet fever

A

Streptococcal pharyngitis and an erythematous punctiform rash due to the Spe toxins

23
Q

Impetigo or pyoderma

A

Infection of the superficial layers of the skin in children - vesicles develop into pustules rupture and crust over

24
Q

Erysipelas

A

Infection of the skin and subcutaneous tissues edema, induration with an distinct advancing border

25
Streptococcal toxic shock
Focal infection, bacteremia, shock hypotension, in conjugation with 2 or more of either ARDS, renal impariment, liver abnormality, coagulopathy, rash
26
Endocarditis
Streptococcal bacteremia allows access to normal, injured or congenitally deformed heart tissue
27
Necrotizing fasciitis
Infection of deeper subcutaneous tissues and fascia, extensive necrosis and gangrene
28
Rheumatic fever (Group A - late sequelae)
Follows respiratory infections, hypersensitivity response to streptococcal antigens
29
Glomerulonephritis (Group A - late sequelae)
Deposition of antigen-antibody complexes in the glomerular basement membrane
30
Streptococcus Pyogenes - Laboratory Diagnosis
``` Gram stain Antigen detection Nucleic acid amplification Culture (gram positive cocci in chains, catalase negative...) Antibodies to streptolysin O ```
31
``` Streptococcus, Prevention and control Pharyngitis: Penicillin allergic patients: Severe: Soft tissue: ```
Pharyngitis: Penicillin, penicillin V amoxicillin Penicillin allergic patients: cephalosporin or macrolide Severe: Penicillin IV + a protein synthesis inhibitor antibiotic Soft Tissue: Surgical debridement and antibiotics
32
S. agalactiae - Group B Physiology and structure: Pathogenisis and immunity: Epidemiology:
Physiology and structure: Expresses group B carbohydrate antigen Pathogenisis and immunity: avoids phagocytosis by expressing a capsule Epidemiology: Asymptomatic colonizatio of the lower gastrointestinal tract and genitourinary tract
33
S. agalactiae: Laboratory diagnosis | Treatment, Prevention and control
Gram stain of CSF for meningitis, pneumonia and wound infections Treatment: drug of choice penicillin G for serious infections penicillin
34
Physiology and structure of S. pneumonia
Encapsulated Gram-positive, elongated or oval coccus arranged in pairs of chains α-hemolytic colonies on blood agar
35
_______ ______ are the basis for the classification of S. Pneumonia strains
Capsular polysaccharides
36
S. Pneumonia - unique cell wall composition of phophorylcholine + species specific teichoic acids (2 types)
C polysaccharide - binds to serum - C-reactive protein a marker for acute inflammation F antigen - cross reacts with Forssman surface antigens on mammalian cells
37
S. Pneumonia pathogenseis Colonization: Resistance: Inflammatory Response:
Colonization: Bacterial colonization is mediated by surface protein adhesins Resistance: S. Pneumonia produces a secretory IgA protease that cleaves the Fc portion of IgA and prevents the association with host mucins Inflammatory Response: Teichoic acids, peptidoglycan - activate complement pathways
38
S. Pneumonia - epidemiology
Transiently colonizes normal healthy individuals Can occur when endogenous oral organisms are aspirated in to the lower airways Disease = breakdown of natural defense mechanisms In children - common cause of otitis media
39
Pneumococcal pneumonia
Replication of bacteria in the alveolar spaces | Abrupt onset, severe chill, sustained fever
40
Sinusitis and Otitis media
Infection of the paranasal sinuses and ear
41
______ occurs in 25-30% of patients with pneumonia and 80% of patients with meningitis
Bacteremia
42
S. Pneumonia laboratory diagnosis
Gram stain Quellung reaction - detection of capsule with antibodies ELISA Culture Isolate tested for bile solubility, should exhibit α-hemolysis on blood agar
43
S. Pneumonia treatment, prevention and control Resistance: Serious Infections:
- Many strains are now resistant to penicillin - Resistance is documented for macrolides and cephalosporins - Serious infections: Vancomycin + ceftriazone followed by monotherapy
44
Immunization: S. pneumonia Adults and Children > 2 yrs: Children < 2 yrs:
Adults and Children > 2 yrs: Immunize with vaccine containing 23 different capsular polysaccharides Children < 2 yrs: Immunize with 13-valent conjugated vaccine